MDxHealth SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy MDxHealth SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MDxHealth SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MDxHealth SA is MDXH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MDxHealth SA has its primary listing on NASDAQ (Small cap). You can trade MDxHealth SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MDxHealth SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include MDxHealth SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like MDxHealth SA.